Is Trump likely to get severe COVID-19? This company thinks genes could reveal clues
October 07, 2020 | Ruth Reader
GoodCell is teaming up with the New York Blood Center to better understand whether there are certain genes that are associated with severe COVID-19. The company hopes the results will better inform the genetic testing it currently offers. The study will look at three groups of people: those without COVID-19, those who experienced a mild form of the illness, and those with the most severe symptoms. Viscomi aims to determine “who gets the sniffles and who ends up in the ICU,” he says. Results of the study should be available by early November.